Share price of Fortis Healthcare fell nearly 2 percent intraday Tuesday as company deferred the approval of quarterly and annual financial results for the period ended March 31, 2018.
The company on Monday deferred the announcement of its results for the March quarter to June 25, citing a need for additional time to consider certain aspects of the Internal Investigation Report comprehensively in its financial accounts.
It also said that the findings are being submitted to Securities Exchange Board of India (SEBI) and Serious Fraud Investigation Officer (SFIO) as well.
On May 30, the company had postponed board meeting scheduled to consider financial results for the fourth quarter and financial year ended March 31, 2018, to June 11
At 10:42 hrs Fortis Healthcare was quoting at Rs 141.25, down Rs 2.35, or 1.64 percent on the BSE.
For Freetrial click here
This post first appeared on After Italy Verdict Gold Trades Higher On Safe-haven Demands; Silver Down, please read the originial post: here
